Clinical course and potential predictive factors for pneumonia of adult patients with Coronavirus Disease 2019 (COVID-19): A retrospective observational analysis of 193 confirmed cases in Thailand
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
-
SciScore for 10.1101/2020.06.24.20139642: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: The study was reviewed and approved by the BIDI’s Institutional Review Board (S012h_63_ExPD). Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources All statistical analyses were performed using SPSS version 26.0 (IBM SPSS Statistics Subscription Trial). SPSSsuggested: (SPSS, RRID:SCR_002865)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing …SciScore for 10.1101/2020.06.24.20139642: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: The study was reviewed and approved by the BIDI’s Institutional Review Board (S012h_63_ExPD). Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources All statistical analyses were performed using SPSS version 26.0 (IBM SPSS Statistics Subscription Trial). SPSSsuggested: (SPSS, RRID:SCR_002865)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:This study has several limitations. First, the findings were based on a relatively small sample size from a single center and may not be generalizable to other settings. However, the proportion of patients in each category of the disease spectrum was comparable with those of nationwide survey of China. This suggests that our sample may be representative of patients with COVID-19 throughout the disease spectrum. Second, the study had risk of recall bias as patients were asked to recall subjective events prior to admission. Third, not all blood chemistry studies were performed in all patients and several non-routine tests (eg, serum LDH, C-reactive protein, IL-6 level) were not investigated. Fourth, we used chest radiograph as radiologic evidence of pneumonia. As chest radiograph is less sensitive than computed tomography, the very mild pneumonia might have been missed. Likewise, arterial blood gas was evaluated only in critical cases, so the incidence of ARDS may not have been correctly estimated. Lastly, our institute has no testing facility for the viral load of SARS-CoV-2 so the duration of viral RNA shedding may not represent the duration of viral viability. In conclusion, the majority of patients with COVID-19 had mild illness. The incidence of pneumonia of any severity was 39% (non-severe in 22%, severe in 14%, critical in 3%). Most patients had a good final clinical outcomes. The case fatality rate in our cohort was 2.1%. Increasing age, obesity, and higher temperature ...
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a protocol registration statement.
-